{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:12:56Z","timestamp":1780341176468,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:00:00Z","timestamp":1536710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:00:00Z","timestamp":1536710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI139473"],"award-info":[{"award-number":["AI139473"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI107678"],"award-info":[{"award-number":["AI107678"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA033371"],"award-info":[{"award-number":["DA033371"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Protein\/subunit vaccines often require external adjuvants to induce protective immunity. Due to the safety concern of chemical adjuvants, physical adjuvants were recently explored to boost vaccination. Physical adjuvants use physical energies rather than chemicals to stimulate tissue stress and endogenous danger signal release to boost vaccination. Here we present the safety and potency of non-invasive radiofrequency treatment to boost intradermal vaccination in murine models. We show non-invasive radiofrequency can increase protein antigen-induced humoral and cellular immune responses with adjuvant effects comparable to widely used chemical adjuvants. Radiofrequency adjuvant can also safely boost pandemic 2009 H1N1 influenza vaccination with adjuvant effects comparable to MF59-like AddaVax adjuvant. We find radiofrequency adjuvant induces heat shock protein 70 (HSP70) release and activates MyD88 to mediate the adjuvant effects. Physical radiofrequency can potentially be a safe and potent adjuvant to augment protein\/subunit vaccine-induced humoral and cellular immune responses.<\/jats:p>","DOI":"10.1038\/s41467-018-06151-y","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T09:35:13Z","timestamp":1536226513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Augmentation of vaccine-induced humoral and cellular immunity by a physical radiofrequency adjuvant"],"prefix":"10.1038","volume":"9","author":[{"given":"Yan","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Nazir","family":"Hossen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prateek","family":"Kakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,12]]},"reference":[{"key":"6151_CR1","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3390\/vaccines2030515","volume":"2","author":"W Li","year":"2014","unstructured":"Li, W., Joshi, M. D., Singhania, S., Ramsey, K. H. & Murthy, A. K. Peptide vaccine: progress and challenges. Vaccines 2, 515\u2013536 (2014).","journal-title":"Vaccines"},{"key":"6151_CR2","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","volume":"82","author":"N Petrovsky","year":"2004","unstructured":"Petrovsky, N. & Aguilar, J. C. Vaccine adjuvants: current state and future trends. Immunol. Cell Biol. 82, 488\u2013496 (2004).","journal-title":"Immunol. Cell Biol."},{"key":"6151_CR3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/vaccines3020320","volume":"3","author":"A Di Pasquale","year":"2015","unstructured":"Di Pasquale, A., Preiss, S., Tavares Da Silva, F. & Garcon, N. Vaccine adjuvants: from 1920 to 2015 and beyond. Vaccines 3, 320\u2013343 (2015).","journal-title":"Vaccines"},{"key":"6151_CR4","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1099\/jmm.0.038943-0","volume":"61","author":"M Kool","year":"2012","unstructured":"Kool, M., Fierens, K. & Lambrecht, B. N. Alum adjuvant: some of the tricks of the oldest adjuvant. J. Med. Microbiol. 61, 927\u2013934 (2012).","journal-title":"J. Med. Microbiol."},{"key":"6151_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1586\/erv.12.140","volume":"12","author":"DT O\u2019Hagan","year":"2013","unstructured":"O\u2019Hagan, D. T., Ott, G. S., Nest, G. V., Rappuoli, R. & Giudice, G. D. The history of MF59((R)) adjuvant: a phoenix that arose from the ashes. Expert. Rev. Vaccin. 12, 13\u201330 (2013).","journal-title":"Expert. Rev. Vaccin."},{"key":"6151_CR6","first-page":"151","volume":"386","author":"G Del Giudice","year":"2015","unstructured":"Del Giudice, G. & Rappuoli, R. Inactivated and adjuvanted influenza vaccines. Curr. Top. Microbiol. Immunol. 386, 151\u2013180 (2015).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"6151_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/srep19570","volume":"6","author":"NP Knudsen","year":"2016","unstructured":"Knudsen, N. P. et al. Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens. Sci. Rep. 6, 19570 (2016).","journal-title":"Sci. Rep."},{"key":"6151_CR8","doi-asserted-by":"publisher","first-page":"21095","DOI":"10.1073\/pnas.1319784110","volume":"110","author":"M Vono","year":"2013","unstructured":"Vono, M. et al. The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination. Proc. Natl Acad. Sci. USA 110, 21095\u201321100 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"6151_CR9","doi-asserted-by":"publisher","first-page":"e1001994","DOI":"10.1371\/journal.pmed.1001994","volume":"13","author":"R Gosling","year":"2016","unstructured":"Gosling, R. & von Seidlein, L. The future of the RTS,S\/AS01 malaria vaccine: an alternative development plan. PLoS Med. 13, e1001994 (2016).","journal-title":"PLoS Med."},{"key":"6151_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/21645515.2016.1225635","volume":"13","author":"N Garcon","year":"2017","unstructured":"Garcon, N. & Di Pasquale, A. From discovery to licensure, the adjuvant system story. Human. Vaccin. Immunother. 13, 19\u201333 (2017).","journal-title":"Human. Vaccin. Immunother."},{"key":"6151_CR11","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1471-4906(02)02276-7","volume":"23","author":"P Rizza","year":"2002","unstructured":"Rizza, P., Ferrantini, M., Capone, I. & Belardelli, F. Cytokines as natural adjuvants for vaccines: where are we now? Trends Immunol. 23, 381\u2013383 (2002).","journal-title":"Trends Immunol."},{"key":"6151_CR12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1084\/jem.103.2.225","volume":"103","author":"AG Johnson","year":"1956","unstructured":"Johnson, A. G., Gaines, S. & Landy, M. Studies on the O antigen of Salmonella typhosa. V. Enhancement of antibody response to protein antigens by the purified lipopolysaccharide. J. Exp. Med. 103, 225\u2013246 (1956).","journal-title":"J. Exp. Med."},{"key":"6151_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nri2215","volume":"8","author":"H Kono","year":"2008","unstructured":"Kono, H. & Rock, K. L. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 8, 279\u2013289 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"6151_CR14","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nri.2017.9","volume":"17","author":"N Yatim","year":"2017","unstructured":"Yatim, N., Cullen, S. & Albert, M. L. Dying cells actively regulate adaptive immune responses. Nat. Rev. Immunol. 17, 262\u2013275 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"6151_CR15","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1084\/jem.20071087","volume":"205","author":"M Kool","year":"2008","unstructured":"Kool, M. et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J. Exp. Med. 205, 869\u2013882 (2008).","journal-title":"J. Exp. Med."},{"key":"6151_CR16","doi-asserted-by":"publisher","first-page":"e82899","DOI":"10.1371\/journal.pone.0082899","volume":"8","author":"S Kashiwagi","year":"2013","unstructured":"Kashiwagi, S. et al. Near-infrared laser adjuvant for influenza vaccine. PLoS ONE 8, e82899 (2013).","journal-title":"PLoS ONE"},{"key":"6151_CR17","doi-asserted-by":"publisher","first-page":"e13776","DOI":"10.1371\/journal.pone.0013776","volume":"5","author":"X Chen","year":"2010","unstructured":"Chen, X. et al. A novel laser vaccine adjuvant increases the motility of antigen presenting cells. PLoS ONE 5, e13776 (2010).","journal-title":"PLoS ONE"},{"key":"6151_CR18","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.4049\/jimmunol.1601873","volume":"199","author":"K Morse","year":"2017","unstructured":"Morse, K. et al. Near-infrared 1064nm laser modulates migratory dendritic cells to augment the immune response to intradermal influenza vaccine. J. Immunol. (Baltim., Md: 1950) 199, 1319\u20131332 (2017).","journal-title":"J. Immunol. (Baltim., Md: 1950)"},{"key":"6151_CR19","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1016\/j.vaccine.2017.03.036","volume":"35","author":"Y Kimizuka","year":"2017","unstructured":"Kimizuka, Y. et al. Semiconductor diode laser device adjuvanting intradermal vaccine. Vaccine 35, 2404\u20132412 (2017).","journal-title":"Vaccine"},{"key":"6151_CR20","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1586\/14760584.2013.844070","volume":"12","author":"X Chen","year":"2013","unstructured":"Chen, X., Wang, J., Shah, D. & Wu, M. X. An update on the use of laser technology in skin vaccination. Expert. Rev. Vaccin. 12, 1313\u20131323 (2013).","journal-title":"Expert. Rev. Vaccin."},{"key":"6151_CR21","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1586\/erv.11.112","volume":"10","author":"X Chen","year":"2011","unstructured":"Chen, X. & Wu, M. X. Laser vaccine adjuvant for cutaneous immunization. Expert. Rev. Vaccin. 10, 1397\u20131403 (2011).","journal-title":"Expert. Rev. Vaccin."},{"key":"6151_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5447","volume":"5","author":"J Wang","year":"2014","unstructured":"Wang, J., Shah, D., Chen, X., Anderson, R. R. & Wu, M. X. A micro-sterile inflammation array as an adjuvant for influenza vaccines. Nat. Commun. 5, 4447 (2014).","journal-title":"Nat. Commun."},{"key":"6151_CR23","doi-asserted-by":"publisher","first-page":"e02156","DOI":"10.1128\/JVI.02156-17","volume":"92","author":"PP Lopes","year":"2018","unstructured":"Lopes, P. P. et al. Laser adjuvant-assisted peptide vaccine promotes skin mobilization of dendritic cells and enhances protective CD8(+) TEM and TRM cell responses against Herpesvirus infection and disease. J. Virol. 92, e02156\u201317 (2018).","journal-title":"J. Virol."},{"key":"6151_CR24","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1016\/j.vaccine.2005.02.027","volume":"23","author":"A Tezel","year":"2005","unstructured":"Tezel, A., Paliwal, S., Shen, Z. & Mitragotri, S. Low-frequency ultrasound as a transcutaneous immunization adjuvant. Vaccine 23, 3800\u20133807 (2005).","journal-title":"Vaccine"},{"key":"6151_CR25","first-page":"259","volume":"8","author":"G Hruza","year":"2009","unstructured":"Hruza, G., Taub, A. F., Collier, S. L. & Mulholland, S. R. Skin rejuvenation and wrinkle reduction using a fractional radiofrequency system. J. Drugs Dermatol. 8, 259\u2013265 (2009).","journal-title":"J. Drugs Dermatol."},{"key":"6151_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1055\/s-0033-1333653","volume":"30","author":"S McDermott","year":"2013","unstructured":"McDermott, S. & Gervais, D. A. Radiofrequency ablation of liver tumors. Semin. Interv. Radiol. 30, 49\u201355 (2013).","journal-title":"Semin. Interv. Radiol."},{"key":"6151_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1084\/jem.20091964","volume":"207","author":"S Henri","year":"2010","unstructured":"Henri, S. et al. CD207+CD103+dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J. Exp. Med. 207, 189\u2013206 (2010).","journal-title":"J. Exp. Med."},{"key":"6151_CR28","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1084\/jem.20131397","volume":"211","author":"N Anandasabapathy","year":"2014","unstructured":"Anandasabapathy, N. et al. Classical Flt3L-dependent dendritic cells control immunity to protein vaccine. J. Exp. Med. 211, 1875\u20131891 (2014).","journal-title":"J. Exp. Med."},{"key":"6151_CR29","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1586\/erv.10.174","volume":"10","author":"C Bode","year":"2011","unstructured":"Bode, C., Zhao, G., Steinhagen, F., Kinjo, T. & Klinman, D. M. CpG DNA as a vaccine adjuvant. Expert. Rev. Vaccin. 10, 499\u2013511 (2011).","journal-title":"Expert. Rev. Vaccin."},{"key":"6151_CR30","doi-asserted-by":"publisher","first-page":"7662","DOI":"10.1016\/j.vaccine.2012.10.006","volume":"30","author":"T Nakayama","year":"2012","unstructured":"Nakayama, T., Kumagai, T., Ishii, K. J. & Ihara, T. Alum-adjuvanted H5N1 whole virion inactivated vaccine (WIV) induced IgG1 and IgG4 antibody responses in young children. Vaccine 30, 7662\u20137666 (2012).","journal-title":"Vaccine"},{"key":"6151_CR31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nri749","volume":"2","author":"P Srivastava","year":"2002","unstructured":"Srivastava, P. Roles of heat-shock proteins in innate and adaptive immunity. Nat. Rev. Immunol. 2, 185\u2013194 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"6151_CR32","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0140-6736(03)14075-5","volume":"362","author":"AG Pockley","year":"2003","unstructured":"Pockley, A. G. Heat shock proteins as regulators of the immune response. Lancet (Lond., Engl.) 362, 469\u2013476 (2003).","journal-title":"Lancet (Lond., Engl.)"},{"key":"6151_CR33","doi-asserted-by":"publisher","first-page":"16363","DOI":"10.1073\/pnas.1108372108","volume":"108","author":"T Imai","year":"2011","unstructured":"Imai, T. et al. Heat shock protein 90 (HSP90) contributes to cytosolic translocation of extracellular antigen for cross-presentation by dendritic cells. Proc. Natl Acad. Sci. USA 108, 16363\u201316368 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"6151_CR34","doi-asserted-by":"publisher","first-page":"35237","DOI":"10.1074\/jbc.R114.619304","volume":"289","author":"L Schaefer","year":"2014","unstructured":"Schaefer, L. Complexity of danger: the diverse nature of damage-associated molecular patterns. J. Biol. Chem. 289, 35237\u201335245 (2014).","journal-title":"J. Biol. Chem."},{"key":"6151_CR35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1097-2765(00)80136-7","volume":"2","author":"R Medzhitov","year":"1998","unstructured":"Medzhitov, R. et al. MyD88 is an adaptor protein in the hToll\/IL-1 receptor family signaling pathways. Mol. Cell 2, 253\u2013258 (1998).","journal-title":"Mol. Cell"},{"key":"6151_CR36","first-page":"414","volume":"3","author":"A Gombault","year":"2012","unstructured":"Gombault, A., Baron, L. & Couillin, I. ATP release and purinergic signaling in NLRP3 inflammasome activation. Front. Immunol. 3, 414 (2012).","journal-title":"Front. Immunol."},{"key":"6151_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/srep39884","volume":"7","author":"TT Braga","year":"2017","unstructured":"Braga, T. T. et al. Soluble Uric Acid Activates the NLRP3 Inflammasome. Sci. Rep. 7, 39884 (2017).","journal-title":"Sci. Rep."},{"key":"6151_CR38","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237\u2013241 (2006).","journal-title":"Nature"},{"key":"6151_CR39","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nri3084","volume":"11","author":"J Neefjes","year":"2011","unstructured":"Neefjes, J., Jongsma, M. L., Paul, P. & Bakke, O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat. Rev. Immunol. 11, 823\u2013836 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"6151_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2013.10.004","volume":"47","author":"C Perricone","year":"2013","unstructured":"Perricone, C. et al. Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects. J. Autoimmun. 47, 1\u201316 (2013).","journal-title":"J. Autoimmun."},{"key":"6151_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.smim.2003.10.003","volume":"16","author":"K Takeda","year":"2004","unstructured":"Takeda, K. & Akira, S. TLR signaling pathways. Semin. Immunol. 16, 3\u20139 (2004).","journal-title":"Semin. Immunol."},{"key":"6151_CR42","doi-asserted-by":"crossref","unstructured":"Ye Y., et al. A melanin-mediated cancer immunotherapy patch. Sci. Immunol. 2 (2017).","DOI":"10.1126\/sciimmunol.aan5692"},{"key":"6151_CR43","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1111\/j.1524-4725.2012.02547.x","volume":"38","author":"MS Lolis","year":"2012","unstructured":"Lolis, M. S. & Goldberg, D. J. Radiofrequency in cosmetic dermatology: a review. Dermatol. Surg. 38, 1765\u20131776 (2012).","journal-title":"Dermatol. Surg."},{"key":"6151_CR44","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/jps.22267","volume":"100","author":"LA Brito","year":"2011","unstructured":"Brito, L. A. & Singh, M. Acceptable levels of endotoxin in vaccine formulations during preclinical research. J. Pharm. Sci. 100, 34\u201337 (2011).","journal-title":"J. Pharm. Sci."},{"key":"6151_CR45","first-page":"19.11","volume":"19","author":"R Cottey","year":"2001","unstructured":"Cottey, R., Rowe, C. A. & Bender, B. S. Influenza virus. Curr. Protoc. Immunol. 19, 19.11 (2001).","journal-title":"Curr. Protoc. Immunol."},{"key":"6151_CR46","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/j.vaccine.2010.12.090","volume":"29","author":"S Calabro","year":"2011","unstructured":"Calabro, S. et al. Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes. Vaccine 29, 1812\u20131823 (2011).","journal-title":"Vaccine"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06151-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06151-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06151-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T17:44:21Z","timestamp":1671558261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-06151-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,12]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["6151"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-06151-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,12]]},"assertion":[{"value":"12 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3695"}}